TheraRadar
← Back
Data updated: Mar 29, 2026

MATRIX LABS LTD

ImmunologyInfectious Disease
Pharma

MATRIX LABS LTD is a pharmaceutical company focused on Immunology, Infectious Disease. Key products include LAMIVUDINE; ZIDOVUDINE.

-
Since
14
Drugs
-
Trials
28
Approved (2yr)

Key Drugs

LAMIVUDINE; ZIDOVUDINE
lamivudine
· 2015

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ATAZANAVIR SULFATE 2025-08-12
Labeling
ATAZANAVIR SULFATE 2025-08-12
Labeling
ATAZANAVIR SULFATE 2025-08-12
Labeling
ATAZANAVIR SULFATE 2025-07-23
Labeling
ATAZANAVIR SULFATE 2025-07-17
Labeling
ATAZANAVIR SULFATE 2025-06-26
Labeling
ATAZANAVIR SULFATE 2025-05-08
Labeling
AMLODIPINE AND OLMESARTAN MEDOXOMIL 2025-05-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%
1 drugs
Infectious Disease 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Immunology
Merck big-pharma
Infectious Disease, Immunology
AbbVie big-pharma
Immunology, Infectious Disease
Johnson & Johnson big-pharma
Immunology, Infectious Disease
GSK big-pharma
Infectious Disease, Immunology